MTOR and neoplasm: Curative treatment with BMS309403 significantly decreased tumor FABP4 (p = 0.04), cyclin D1 (p = 0.02), VEGFA (p = 0.002) and VEGFR (p = 0.001) expression compared to the control group, while active caspase 3 was induced (p = 0.008) in parallel with mTOR pathway downregulation.